Genolution Inc. (KOSDAQ:225220)
South Korea · Delayed Price · Currency is KRW 1,810.00
-16.00 (-0.88%)
At close: Apr 2, 2026
Genolution Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | 8,981 | 7,136 | 9,761 | 38,085 |
Other Revenue | 423 | -0 | - | -0 |
| 9,404 | 7,136 | 9,761 | 38,085 | |
Revenue Growth (YoY) | 31.79% | -26.90% | -74.37% | - |
Cost of Revenue | 5,962 | 4,836 | 5,304 | 12,177 |
Gross Profit | 3,442 | 2,300 | 4,457 | 25,907 |
Selling, General & Admin | 9,545 | 7,940 | 7,142 | 8,660 |
Research & Development | 471.61 | 1,672 | 3,081 | 1,516 |
Amortization of Goodwill & Intangibles | 47.19 | 42.79 | 32.16 | 22.38 |
Other Operating Expenses | 272.93 | 252.32 | 330.46 | -18.12 |
Operating Expenses | 12,084 | 11,464 | 11,549 | 11,171 |
Operating Income | -8,642 | -9,164 | -7,091 | 14,737 |
Interest Expense | -875.62 | -418.09 | - | -311.61 |
Interest & Investment Income | 1,194 | 1,808 | 1,835 | 665.52 |
Earnings From Equity Investments | - | -103.43 | 382.21 | -144.85 |
Currency Exchange Gain (Loss) | -605.26 | 4,114 | 377.64 | 1,703 |
Other Non Operating Income (Expenses) | 304.85 | 126.9 | 19.02 | 568.26 |
EBT Excluding Unusual Items | -8,624 | -3,637 | -4,477 | 17,217 |
Gain (Loss) on Sale of Investments | -1,793 | -3,118 | 542.13 | -459.01 |
Gain (Loss) on Sale of Assets | -25.56 | - | -2,577 | 218.54 |
Asset Writedown | -2,143 | -17 | -141.55 | - |
Other Unusual Items | - | - | - | 262.4 |
Pretax Income | -12,586 | -6,771 | -6,653 | 17,239 |
Income Tax Expense | 3.9 | 437.36 | -1,103 | 2,637 |
Earnings From Continuing Operations | -12,590 | -7,209 | -5,550 | 14,602 |
Minority Interest in Earnings | 947.03 | 383.22 | 38.75 | - |
Net Income | -11,643 | -6,826 | -5,512 | 14,602 |
Net Income to Common | -11,643 | -6,826 | -5,512 | 14,602 |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 19 |
Shares Change (YoY) | 0.12% | -1.57% | -2.81% | - |
EPS (Basic) | -644.00 | -378.00 | -300.43 | 800.93 |
EPS (Diluted) | -644.00 | -378.00 | -300.43 | 768.91 |
Free Cash Flow | -7,308 | -13,558 | -7,940 | -8,955 |
Free Cash Flow Per Share | -404.23 | -750.83 | -432.81 | -474.38 |
Gross Margin | 36.60% | 32.23% | 45.66% | 68.03% |
Operating Margin | -91.89% | -128.42% | -72.65% | 38.70% |
Profit Margin | -123.80% | -95.65% | -56.46% | 38.34% |
Free Cash Flow Margin | -77.71% | -190.00% | -81.34% | -23.51% |
EBITDA | -6,279 | -7,123 | -5,513 | 16,065 |
EBITDA Margin | -66.76% | -99.82% | -56.48% | 42.18% |
D&A For EBITDA | 2,363 | 2,041 | 1,578 | 1,328 |
EBIT | -8,642 | -9,164 | -7,091 | 14,737 |
EBIT Margin | -91.89% | -128.42% | -72.65% | 38.70% |
Effective Tax Rate | - | - | - | 15.30% |
Advertising Expenses | 807.78 | 470.47 | 343.49 | 435.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.